Our study, therefore, identifies for the first time the DNMT3A-STAT5B-MBP axis in oligodendrocytes as a direct regulatory pathway, providing compelling evidence for DNMT3A-driven glial epigenetic dysregulation and subsequent myelin injury in PD pathogenesis. This evidence concerns the gene MBP and Parkinson disease.